Hydrogenology
Hydrogenology editorial study record

Hydrogen does not exert neuroprotective effects or improve functional outcomes in rats after intracerebral hemorrhage

Takeuchi S, Nagatani K, Otani N, Wada K, Mori K. · Turk Neurosurg. 2016;26(6):854–859.

PreclinicalInhaled H₂Published 2016
Study record, not medical adviceThis page reports one source and Hydrogenology’s source-text extraction. It does not establish that molecular hydrogen is effective, safe or appropriate for any person. Human, animal and laboratory evidence must not be treated as equivalent.
Source and classification

What kind of evidence is this?

Evidence stream

Preclinical

Reported design

Controlled rat study

Research topic

Other neurological conditions

Administration classification

Inhaled H₂

Study result signal

No clear treatment signal.

Outcome type

Functional, tissue and biomarker outcomes in a rat model.

Reported in the source

Methods at a glance

Population or model

Rats in an experimental intracerebral-hemorrhage model.

Sample

Animal groups and analyzed counts were checked in the article.

Duration

Acute post-injury protocol.

Intervention

Hydrogen gas inhalation after intracerebral hemorrhage.

Hydrogen form

Inhaled H₂-containing gas.

H₂ specification

The checked methods report the gas exposure protocol.

H₂ flow

See the linked full methods for chamber delivery.

O₂ delivered with H₂

Comparator gas conditions were checked in the full article.

Comparator

Hemorrhage animals without H₂ exposure and sham controls.

Reported, not endorsed

Outcomes and reported result

Outcomes measured

Neurological function, edema, oxidative markers and tissue injury.

Reported result

The article did not find amelioration of the main intracerebral-hemorrhage outcomes with the reported H₂ protocol.

Results-extraction completeness

The full article methods, intervention, outcomes, positive and null findings, funding and conflict statements were checked.

A reported association, difference or mechanism is not automatically a clinical benefit. Null findings, outcome type, study design and precision all matter.

Interpretation limits

Cautions and applicability

Design and reporting cautions

A null result in one animal model does not determine clinical effects.

Applies directly to

The reported rat hemorrhage model and protocol only.

Preliminary appraisal framework

SYRCLE animal-study tool — preliminary

Preliminary risk-of-bias status

Some concerns

Appraisal rationale

Controlled groups were used, but sequence generation, concealment and blinded outcome assessment were not fully established.

Appraisal domains

Sequence generation checked where reported · Allocation concealment generally unclear · Personnel blinding generally unclear · Outcome-assessor blinding generally unclear · No prospectively registered analysis plan identified

No single-study GRADE certainty rating is assigned. Certainty is assessed by important outcome across a complete eligible evidence set, not by attaching a final grade to one source.

Provenance

Sources and record status

Identifiers

PMID: 27801926 · DOI: 10.5137/1019-5149.jtn.14098-15.1

Publisher access

A free publisher or repository full article was checked.

Extraction basis

Publisher or repository full article and bibliographic record; checked 10 August 2026.

Record revision

2026-08-10